News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,429 Results
Type
Article (1701)
Company Profile (2)
Press Release (8726)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (4078)
Career Advice (67)
Deals (416)
Drug Delivery (5)
Drug Development (2231)
Employer Resources (14)
FDA (447)
Job Trends (463)
News (6861)
Policy (587)
Tag
Academia (34)
Accelerated approval (3)
Allergies (6)
Alliances (951)
ALS (1)
Alzheimer's disease (48)
Antibody-drug conjugate (ADC) (12)
Approvals (463)
Artificial intelligence (20)
Autoimmune disease (15)
Automation (2)
Bankruptcy (3)
Best Places to Work (330)
Biosimilars (14)
Biotechnology (2)
Bladder cancer (8)
Brain cancer (4)
Breast cancer (49)
Cancer (208)
Cardiovascular disease (5)
Career advice (62)
CAR-T (1)
Cell therapy (14)
Cervical cancer (2)
Clinical research (1911)
Collaboration (53)
Complete response letters (3)
COVID-19 (97)
C-suite (61)
Cystic fibrosis (2)
Data (162)
Dermatology (1)
Diabetes (11)
Diagnostics (89)
Diversity, equity & inclusion (3)
Drug discovery (9)
Drug pricing (6)
Duchenne muscular dystrophy (5)
Earnings (1025)
Editorial (2)
Employer branding (7)
Employer resources (13)
Events (1059)
Executive appointments (52)
FDA (518)
Funding (28)
Generative AI (3)
Gene therapy (12)
GLP-1 (30)
Government (95)
Guidances (2)
Healthcare (158)
HIV (2)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (13)
Immuno-oncology (2)
Indications (2)
Infectious disease (102)
Inflammatory bowel disease (4)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (4)
Interviews (13)
IPO (175)
IRA (2)
Job creations (138)
Job search strategy (56)
JPM (1)
Labor market (4)
Layoffs (41)
Leadership (1)
Legal (104)
Liver cancer (10)
Lung cancer (23)
Lymphoma (40)
Management (4)
Manufacturing (22)
MASH (1)
Medical device (29)
Medtech (29)
Mergers & acquisitions (251)
Metabolic disorders (25)
mRNA (13)
Multiple sclerosis (19)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (76)
NextGen: Class of 2026 (143)
Non-profit (55)
Now hiring (1)
Obesity (12)
Opinion (25)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (6)
Parkinson's disease (6)
Patents (6)
Patient recruitment (2)
Peanut (4)
People (2030)
Pharmaceutical (1)
Phase 1 (585)
Phase 2 (710)
Phase 3 (933)
Pipeline (155)
Policy (8)
Postmarket research (81)
Preclinical (132)
Press Release (1)
Prostate cancer (1)
Radiopharmaceuticals (3)
Rare diseases (18)
Real estate (75)
Recruiting (5)
Regulatory (511)
Reports (3)
Research institute (37)
Resumes & cover letters (5)
RSV (2)
Series A (7)
Series B (7)
Sickle cell disease (1)
Special edition (2)
Spinal muscular atrophy (44)
Sponsored (1)
Startups (123)
Stomach cancer (3)
Supply chain (1)
Tariffs (1)
The Weekly (4)
Vaccines (27)
Venture capital (4)
Weight loss (7)
Date
Last 7 days (9)
Last 30 days (43)
Last 365 days (461)
2026 (208)
2025 (465)
2024 (474)
2023 (530)
2022 (832)
2021 (835)
2020 (749)
2019 (787)
2018 (662)
2017 (648)
2016 (508)
2015 (628)
2014 (361)
2013 (251)
2012 (280)
2011 (306)
2010 (253)
Location
Africa (45)
Arizona (9)
Asia (600)
Australia (203)
California (280)
Canada (24)
China (8)
Colorado (4)
Connecticut (1)
Delaware (2)
Europe (1896)
Florida (2)
Illinois (14)
Indiana (14)
Japan (2)
Kentucky (3)
Maryland (5)
Massachusetts (103)
Minnesota (2)
Nevada (2)
New Jersey (30)
New York (19)
North Carolina (16)
Northern California (182)
Ohio (2)
Oregon (1)
Pennsylvania (10)
Rhode Island (1)
South America (45)
Southern California (62)
Texas (30)
United States (554)
Utah (9)
Virginia (2)
Washington State (16)
Wisconsin (1)
10,429 Results for "genentech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
·
10 min read
Layoffs
Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year
Genentech is letting go of 118 employees in South San Francisco. The news comes about two months after the biotech ended a partnership with Adaptive Biotechnologies.
October 29, 2025
·
1 min read
·
Angela Gabriel
Press Releases
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
14 min read
Press Releases
CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
15 min read
Press Releases
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
April 22, 2026
·
12 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
·
15 min read
Press Releases
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
May 26, 2026
·
5 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
·
15 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
·
19 min read
Press Releases
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
February 20, 2026
·
17 min read
1 of 1,043
Next
